Skip to main content

Medical Management of Patients with Rhino-Orbito-Cerebral Mucormycosis

  • Chapter
  • First Online:
Book cover Rhino-Orbito-Cerebral Mucormycosis
  • 301 Accesses

Abstract

COVID-19 pandemic has led to the emergence of a new deadly invasive mucormycosis infection. Mucormycosis is a devastating disease inflicting lethal damage to humankind. A holistic approach is the need of the hour for the thorough medical evaluation of a COVID patient with mucormycosis. It needs diligent multidisciplinary care to save mucormycosis patients. It is essential to have in-depth knowledge of various underlying disease processes to timely implement the latest treatment protocols. Management of underlying comorbid conditions seriously impacts overall recovery and outcome. This chapter describes a stepwise approach for the evaluation and treatment of mucormycosis patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.

    Article  Google Scholar 

  2. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med. 1999;159(12):1301–9.

    Article  CAS  Google Scholar 

  3. Smith JA, Kauffman CA. Pulmonary fungal infections. Respirology. 2012;17(6):913–26.

    Article  Google Scholar 

  4. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327–34.

    Article  Google Scholar 

  5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl. 1):S81–90.

    Article  Google Scholar 

  6. National Diabetes and Diabetic Retinopathy Survey report 2019.

    Google Scholar 

  7. Umpierrez G, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.

    Article  CAS  Google Scholar 

  8. Moghissi ES, Korytkowski MT, Dinardo MM, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.

    Article  Google Scholar 

  9. Government of India Ministry of Health & Family Welfare. Clinical guidance on diagnosis and management of diabetes at COVID-19 patient management facility version 2.0.

    Google Scholar 

  10. Rayman G, Lumb A, Kennon B, et al. New guidance on managing inpatient hyperglycaemia during the COVID-19 pandemic. Diabet Med. 2020;37(7):1210–3. https://doi.org/10.1111/dme.14327.

    Article  CAS  PubMed  Google Scholar 

  11. Kelly JL. Continuous insulin infusion: when, where, and how? Diabetes Spectr. 2014;27(3):218–23.

    Article  Google Scholar 

  12. Gupta Y, Goyal A, Kubihal S, Golla KK, Tandon N. A guidance on diagnosis and management of hyperglycemia at COVID care facilities in India. Diabetes Metab Syndr. 2021;15(1):407–13.

    Article  Google Scholar 

  13. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia [published online ahead of print March 13 2020]. J Thromb Haemost. 2020;18(4):844–7. https://doi.org/10.1111/jth.14768.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020; https://doi.org/10.1016/j.jacc.2020.04.031.

  15. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. [Published online ahead of print April 9 20202]. J Thromb Haemost. 2020; https://doi.org/10.1111/jth.14830.

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bansal, B.S. (2022). Medical Management of Patients with Rhino-Orbito-Cerebral Mucormycosis. In: Gupta, N., Honavar, S.G. (eds) Rhino-Orbito-Cerebral Mucormycosis. Springer, Singapore. https://doi.org/10.1007/978-981-16-9729-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-9729-6_16

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-9728-9

  • Online ISBN: 978-981-16-9729-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics